Zydus Cadila has received the final approval from the USFDA to market Clobetasol Propionate Lotion, (US RLD - Clobex Lotion), 0.05%. This medication is used to treat a variety
of skin conditions like eczema, psoriasis, dermatitis, allergies and rash. Clobctasol reduces the
swelling, itching and redness that can occur in these types of conditions. It will be
manufactured at the group's Topical manufacturing facility at Ahmedabad.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
